Protagonist Therapeutics

Protagonist Therapeutics

Quarterly Financials

Values in thousands2026-09-302026-06-302026-03-312025-12-31
Revenue
$274,410
$213,475
$56,368
$7,437
Gross Profit
273,310
213,475
55,961
7,437
EBITDA
226,571
165,511
2,688
-43,342
EBIT
218,332
165,114
2,281
-43,718
Net Income
220,015
162,849
3,783
-44,384
Net Change In Cash
274,410
213,475
56,368
7,437
Free Cash Flow
-23,458
218,884
-49,158
-37,119
Cash
498,298
420,078
193,712
128,390
Basic Shares
71,731
71,007
70,492
63,573

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$46,016
$434,433
$60,000
$26,581
Gross Profit
44,791
434,433
60,000
26,581
EBITDA
-128,031
282,371
-75,643
-128,004
EBIT
-129,311
279,408
-78,955
-131,373
Net Income
-130,149
275,188
-78,955
-123,413
Net Change In Cash
46,016
434,433
60,000
26,581
Cost of Revenue
2,169
Free Cash Flow
56,081
182,797
-70,845
-108,932
Cash
128,390
97,249
186,727
125,744
Basic Shares
63,573
65,078
56,763
49,042

Earnings Calls

QuarterEPS
2026-09-30
$3.07
2026-06-30
$2.29
2026-03-31
$0.05
2025-12-31
-$0.69